Stability and viscosity of a flavored omeprazole oral suspension for pediatric use-Reference-Cited by-同舟云学术

Stability and viscosity of a flavored omeprazole oral suspension for pediatric use

Published:2006-11-15 Issue:22 Volume:63 Page:2240-2247
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Burnett Jane E.¹,Balkin Ethan R.²

Affiliation:

1. Department of Surgery, University of Missouri Hospital and Clinics (UMHC), Columbia

2. Area of Pathobiology, Harry S. Truman Memorial Veterans’ Hospital, Columbia; at the time of the study he was Senior Research Laboratory Technician, Department of Surgery, UMHC

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/63/22/2240/28329819/ajhp2240.pdf

Reference26 articles.

1. Selective Inhibition of the Gastric H+, K+-ATPase by Omeprazole and Related Compounds

2. Omeprazole and Other Proton Pump Inhibitors: Pharmacology, Efficacy, and Safety, with Special Reference to Use in Children

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug administration via feeding tubes—a procedure that carries risks: systematic identification of critical factors based on commonly administered drugs in a cohort of stroke patients;European Journal of Clinical Pharmacology;2024-07-29

2. Pellets and gummies: Seeking a 3D printed gastro-resistant omeprazole dosage for paediatric administration;International Journal of Pharmaceutics;2023-08

3. A Critical Assessment of Extemporaneous Formulations for Proton Pump Inhibitors: The Importance of Proper Vehicle Selection;The Journal of Pediatric Pharmacology and Therapeutics;2022-09-01

4. Stability of omeprazole in a commercial calcium carbonate based oral suspension at 2, 5 and 10 mg/mL stored under refrigeration (4°C) for 70 days;Journal of Pharmacy Practice and Research;2022-02

5. Implementation and in vitro characterization of calcium-free in situ gelling oral reconstituted suspension for potential overweight treatment;Drug Development and Industrial Pharmacy;2020-12-14